(Q71820030)

English

Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle

scientific article published on 01 November 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

based on heuristic

inferred from title

author name string

A K van Vliet

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Nègre-Aminou

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

G C van Thiel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P A Bolhuis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

L H Cohen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

0 references

publication date

1 November 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1387-1392

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Tissue-selective action of pravastatin due to hepatocellular uptake via a sodium-independent bile acid transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Effects of a competitive inhibitor (mevinolin) of 3-hydroxy-3-methylglutaryl coenzyme A reductase on human and bovine endothelial cells, fibroblasts and smooth muscle cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Efficacy and long-term adverse effect pattern of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Plasma mevalonate response in lovastatin-related myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Lovastatin and rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Lovastatin, isoprenes, and myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Rhabdomyolysis and simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Rhabdomyolysis with simvastatin use

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Pravastatin-Associated Inflammatory Myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Cholesterol-lowering agent myopathy (CLAM)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Studies on the effect of mevinolin (lovastatin) and mevastatin (compactin) on the fusion of L6 myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

The regeneration of skeletal muscle. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

Posttranslational modification of proteins by isoprenoids in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900467-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(96)00467-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937448%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71820030&oldid=1933554749"